EMC Capital Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
EMC Capital Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$460,000
-7.8%
61,3940.0%0.25%
-10.8%
Q3 2021$499,000
-32.1%
61,3940.0%0.28%
-33.3%
Q2 2021$735,000
-18.6%
61,394
-14.8%
0.42%
-35.1%
Q1 2021$903,000
+18.0%
72,061
+47.1%
0.64%
+10.3%
Q4 2020$765,00048,9920.58%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders